Mesoblast: a story of Australian innovation

The case study examines the development of stem cell technology company Mesoblast. It is an innovation success story and it also shows how support from the Australian Government has contributed to the company’s success.

Mesoblast’s technology enables the identification, efficient extraction and scale-up of adult mesenchymal precursor (stem) cells from bone marrow. The technology has potentially wide application in regenerative medicine, with conditions being targeted including: cardiovascular disease; bone marrow transplant; degenerative disc disease; spinal fusion; diabetes and osteoarthritis.

Mesoblast: a story of Australian innovation 

Share this Page